These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 13148854)

  • 1. [Advantages of hyaluronidase in the Sakel cure; preliminary clinical results].
    RONDEPIERRE J; HYVERT P; HENNE M; MARTY R; HAIM A; JAY M
    Ann Med Psychol (Paris); 1953 Dec; 111(2 5):692-6. PubMed ID: 13148854
    [No Abstract]   [Full Text] [Related]  

  • 2. [Insulin sensitivity in schizophrenia; insulin economy with hyaluronidase].
    JOST F
    Wien Klin Wochenschr; 1958 Sep; 70(36):657-61. PubMed ID: 13593351
    [No Abstract]   [Full Text] [Related]  

  • 3. [Amorphous insulin & hyaluronidase in insulin treatment of psychoses].
    KEUP W
    Schweiz Med Wochenschr; 1957 Aug; 87(35-36):1128-31. PubMed ID: 13467192
    [No Abstract]   [Full Text] [Related]  

  • 4. [Association of hyaluronidase to insulin in the Sakel treatment].
    DEMAY G; MISES R; BORIES J; CHANOIT P
    Ann Med Psychol (Paris); 1953 Oct; 111(2 3):339-42. PubMed ID: 13105040
    [No Abstract]   [Full Text] [Related]  

  • 5. [USE OF HYALURONIDASE IN SAKEL THERAPY AND ITS ADVANTAGES].
    MOUTOUSES NK; GIANNAKOURAS I; GKOUMAS A
    Hell Iatr; 1964 Feb; 33():146-58. PubMed ID: 14140052
    [No Abstract]   [Full Text] [Related]  

  • 6. Measurements of effects of hyaluronidase in insulin coma treatment.
    SCHMIDT KE; TONG J
    J Ment Sci; 1958 Oct; 104(437):1136-48. PubMed ID: 13621159
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hyaluronidase in the Sakel method].
    ROSA JJ; MIR VILLANUEVA JR; BLOCK DE
    Prensa Med Argent; 1959 May; 46():1196-8. PubMed ID: 14438779
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of hyaluronidase in insulin coma.
    PARGITER RA
    Dis Nerv Syst; 1957 May; 18(5):194-5. PubMed ID: 13427658
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of hyaluronidase in insulin coma therapy.
    HOLDEN JC; MCGUINNESS OL
    Br Med J; 1957 Jul; 2(5036):85-6. PubMed ID: 13436864
    [No Abstract]   [Full Text] [Related]  

  • 10. Hyaluronidase as an adjuvant in insulin shock therapy.
    TYNDEL M
    J Am Med Assoc; 1956 Sep; 162(1):32-4. PubMed ID: 13357285
    [No Abstract]   [Full Text] [Related]  

  • 11. Hyaluronidase in insulin coma therapy.
    GYSIN WM; WILSON JL
    Dis Nerv Syst; 1954 May; 15(5):138-41. PubMed ID: 13161747
    [No Abstract]   [Full Text] [Related]  

  • 12. [Responsibilities after a fatal accident occurring during a Sakel cure].
    Kornprobst L
    Presse Med (1893); 1968 Apr; 76(21):1025-8. PubMed ID: 5655977
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of hyaluronidase with insulin in insulin coma therapy.
    ALEXANDER SP; NEANDER JF
    Psychiatr Q; 1956 Jan; 30(1):89-95. PubMed ID: 13323102
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ambulatory psychotherapy of schizophrenia after the Sakel or neuroleptic cure].
    HELD R
    Sem Hop Ther Paris; 1960 Apr; 36():329-33. PubMed ID: 14400831
    [No Abstract]   [Full Text] [Related]  

  • 15. A new aid to insulin coma therapy.
    GREENBANK RK
    Psychiatr Q; 1954 Jul; 28(3):395-7. PubMed ID: 13204475
    [No Abstract]   [Full Text] [Related]  

  • 16. [Drawings of a schizophrenic during a Sakel cure].
    Michaux L; Gallot HM; Schneider JJ
    Ann Med Psychol (Paris); 1967 Jul; 125(2):286-90. PubMed ID: 4864794
    [No Abstract]   [Full Text] [Related]  

  • 17. [Insulin potentiators in the Sakel cure: hyaluronidase & carbutamide].
    RACAMIER PC; BLANCHARD M; CARRETIER L
    Ann Med Psychol (Paris); 1958 Oct; 2(3):462-80. PubMed ID: 13606544
    [No Abstract]   [Full Text] [Related]  

  • 18. [Psychotherapeutic experience with a new schizophrenic patient treated with insulin, using the Sakel method].
    Pavan L
    G Psichiatr Neuropatol; 1968; 96(2):267-84. PubMed ID: 5713122
    [No Abstract]   [Full Text] [Related]  

  • 19. Hyaluronidase in the treatment of local inflammatory effects following intravenous injection of 50% glucose.
    PETRUS J; PISETSKY J
    Am J Psychiatry; 1952 Oct; 109(4):303-4. PubMed ID: 12976555
    [No Abstract]   [Full Text] [Related]  

  • 20. Hazard of the Sakel treatment in insulin potentiation by means of ganglionic-blocking agents of the methonium group and tolbutamide.
    Hosák L; Komenda S; Hosáková Z; Benes O
    Act Nerv Super (Praha); 1965 Aug; 7(3):245-6. PubMed ID: 5882093
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.